MacroGenics Inc (NASDAQ:MGNX)
| 10.59 Delayed Data As of Dec 13 |  +0.26 / +2.52%Today’s Change | 7.43 Today|||52-Week Range 32.32 | -16.61% Year-to-Date |
Latest MGNX News | Press Releases
No recent news for MacroGenics Inc.
Today’s Trading
| Previous close | 10.33 |
| Today’s open | 10.31 |
| Day’s range | 10.15 - 10.67 |
| Volume | 471,723 |
| Average volume (3 months) | 493,887 |
| Market cap | $518.0M |
Data as of 4:00pm ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | -675.81% |
| Earnings growth (this year) | +19.73% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -61.89% |
| P/E ratio | NM |
| Price/Sales | 8.65 |
| Price/Book | 1.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STMLStemline Therapeutic... | -0.15 | -1.47% |
| CRNXCrinetics Pharmaceut... | 0.00 | 0.00% |
| PRVBProvention Bio Inc | +0.53 | +4.73% |
| LXRXLexicon Pharmaceutic... | -0.21 | -4.14% |
Data as of 4:00pm ET, 12/13/2019
Financials
| Next reporting date | February 27, 2020 |
| EPS forecast (this quarter) | -$0.81 |
| Annual revenue (last year) | $60.1M |
| Annual profit (last year) | -$171.5M |
| Net profit margin | -285.18% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
